UWEFF - U3O8 Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0545
-0.0025 (-4.32%)
At close: 12:35PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close0.0570
Open0.0545
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0545 - 0.0545
52 Week Range0.0100 - 0.9000
Volume322
Avg. Volume10,528
Market Cap1.348M
Beta (5Y Monthly)2.33
PE Ratio (TTM)N/A
EPS (TTM)-0.0600
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • GlobeNewswire

      U3O8 Corp. To Resume Trading

      U3O8 Corp. (NEX: UWE.H), (“U3O8” or the “Company”) reports that, further to the press release dated March 30, 2020, announcing that the Company would not be proceeding with the reverse takeover described in its March 2, 2020 press release, the Company’s submission to TSX Venture Exchange for the lifting of the halt on trading of the Company’s shares, has been accepted. Subject to final regulatory approval, trading of the Company’s common shares will resume on the NEX on opening of the market today, April 27, 2020. Company will continue to evaluate acquisition opportunities and other business opportunities that may become available to it in the context of the market, and of a strengthening uranium price, with a view to completing a reactivation transaction in accordance with the policies of the TSX Venture Exchange.

    • GlobeNewswire

      U3O8 Corp. Announces the Termination of the Binding Letter of Intent with Diagnostic Lab Corporation, Inc. and Postpones Reporting of Fourth Quarter and 2019 Full-Year Reporting Due to Delays Caused by COVID-19 Pandemic

      U3O8 Corp. (NEX: UWE.H), (OTCQB: UWEFF) (“U3O8” or the “Company”) announces that, further to the press release dated March 2, 2020, the letter of intent (“LOI”) between the Company and Diagnostic Lab Corporation, Inc. to negotiate and complete a proposed reactivation transaction, has been terminated in accordance with the provisions of the LOI, and the transaction contemplated therein will not proceed. The Company will continue to evaluate other acquisition opportunities with a view to completing a reactivation transaction in accordance with the policies of the TSX Venture Exchange. Submissions are being made to the TSX Venture Exchange to allow for the resumption of trading.

    • GlobeNewswire

      U3O8 Corp. Announces Proposed Reverse Takeover Transaction with Diagnostic Lab Corporation, Inc.

      U3O8 Corp. (NEX: UWE.H), (OTCQB: UWEFF) (“U3O8” or the “Company”) announces that it has entered into a binding Letter of Intent (“LOI”) dated March 2, 2020 with Diagnostic Lab Corporation, Inc. (“DLC”) whereby the business and assets of U3O8 Corp. and DLC will be combined by way of a share exchange between U3O8 Corp. and shareholders of DLC, constituting a “reverse-takeover” of U3O8 Corp. by DLC (the “Proposed Transaction”) under the policies of the TSX Venture Exchange (the “TSXV” or the “Exchange”).

    • GlobeNewswire

      U3O8 Corp. Updates on Transfer to NEX Board

      U3O8 Corp. (TSX: UWE), (OTCQB: UWEFF) (“U3O8” or the “Company”) announces that, further to its press release date February 24, 2020, the Company’s listing will transfer to the NEX board of the TSX Venture Exchange effective February 27, 2020 and not February 26, 2020. The trading symbol for the Company will change from UWE to UWE.H. There is no change in the Company's name, no change in its CUSIP number and no consolidation of capital. The symbol extension differentiates NEX symbols from Tier 1 or Tier 2 symbols within the TSX Venture Exchange.

    • GlobeNewswire

      U3O8 Corp. Announces Transfer to NEX Board

      U3O8 Corp. (TSX: UWE), (OTCQB: UWEFF) (“U3O8” or the “Company”) announces that effective February 26, 2020 the Company's listing will transfer to the NEX board of the TSX Venture Exchange. The trading symbol for the Company will change from UWE to UWE.H. There is no change in the Company's name, no change in its CUSIP number and no consolidation of capital. The symbol extension differentiates NEX symbols from Tier 1 or Tier 2 symbols within the TSX Venture Exchange.

    • Introducing U3O8 (TSE:UWE), The Stock That Tanked 94%
      Simply Wall St.

      Introducing U3O8 (TSE:UWE), The Stock That Tanked 94%

      We're definitely into long term investing, but some companies are simply bad investments over any time frame. It hits...

    • U3O8 Corp. Announces Results of Annual General Shareholder Meeting
      Newsfile

      U3O8 Corp. Announces Results of Annual General Shareholder Meeting

      Toronto, Ontario--(Newsfile Corp. - June 26, 2019) - U3O8 Corp. (TSX: UWE) (OTCQB: UWEFF) ("U3O8 Corp." or the "Company") reports that all matters brought before its shareholders were approved at the Annual General Meeting ("AGM") held yesterday in Toronto, Ontario. A total of 6,644,075 of the Corporation's common shares were voted by proxy and in person, representing 28.83% of the 23,043,436 shares outstanding on May 13, 2019, the record date of the ...